Search

This study investigated the individual and combined effects of mental fatigue (MF) and hypoxia (HYP) on physical and cognitive performance. Fifteen males (24 ± 3 years) completed one familiarization session and six experimental trials, including: 1) normoxia (0.209 FiO2) and no MF; 2) normoxia (0.209 FiO2) with MF; 3) mild normobaric HYP (0.13 FiO2) and no MF; 4) mild normobaric HYP (0.13 FiO2) with MF; 5) severe normobaric HYP (0.10 FiO2) and no MF; 6) severe normobaric HYP (0.10 FiO2) with MF. Each condition included a 15-min self-paced time trial, followed by a 60-s isometric maximal voluntary contraction of the biceps brachii. MF was induced using a 16-min individualized cognitive test prior to exercise performance. Following each time trial, participants performed the Tower of Hanoi cognitive test. A main effect of HYP was observed on average power output, oxygen consumption and muscle oxygenation (P ≤ 0.004), with no effect of MF (P ≥ 0.599). Voluntary activation of the biceps brachii was also reduced in HYP (68.42 ± 5.64%, P = 0.039). No effect of MF or HYP was observed on cognitive performance (P ≥ 0.138). HYP impacted physical performance, whilst MF had no effect on self-paced physical or cognitive performance. [ABSTRACT FROM AUTHOR]

• We postulate that heat stress, in addition to a VR stimulus may trigger a heightened nauseogenic response and VIMS. • Data does not provide unequivocal evidence of a synergistic interaction between a heat exposure and VR use on VIMS. • Despite no statistical synergistic interaction, trends towards synergism were seen in VIMS questionnaire data, vasomotor and sudomotor activity. • Considerable individual variation was seen in resistance to motion sickness, limiting the statistical power available for a significant interaction. • Vasomotor activity showed conflict between the vasoconstriction induced by VR and vasodilatation induced by heat. Virtual reality (VR) use is limited by the potential side effects of prolonged exposure to vection, leading to motion sickness. Air temperature (T a) may exacerbate the severity of such side effects through a synergistic interaction. This study assessed the individual and combined impact of a hot T a and VR on motion sickness severity. Thirteen healthy volunteers were exposed to a 20 min visual stimulus, across four experimental conditions: N_CS: 22 °C T a with computer screen; N_VR: 22 °C T a with VR; H_CS: 35 °C T a with computer screen; H_VR: 35 °C T a with VR. Motion sickness was assessed via fast motion sickness scale (FMS) and simulator sickness questionnaire (SSQ). Physiological indices of motion sickness including, sweat rate, rectal temperature, cutaneous vascular conductance (CVC), skin temperature, blood pressure and heart rate were also examined. FMS and SSQ ratings indicate a significant main effect for VR, increasing sickness severity (p < 0.001). A significant main effect of T a was observed for SSQ, but not FMS ratings (FMS, p = 0.07; SSQ, p < 0.04). Despite trends towards synergism, no interaction (T a × VR) was observed for FMS (p = 0.2) or SSQ scores (p = 0.07), indicating an additive response. Synergistic trends were also observed for sweat rate and CVC. Synergism between VR and heat on motion sickness remains unclear, possibly as a result of considerable inter-individual variation in the reported subjective responses. Understanding of the questions raised by this study inform safe working guidelines for the use of VR in commercial and occupational settings. [ABSTRACT FROM AUTHOR]

The development of vaccines against Staphylococcus aureus has consistently failed in clinical trials, likely due to inefficient induction of cellular immunity. T cell-derived IL-17 is one of the few known correlates of antistaphylococcoal immunity, conferring protection against S. aureus infections through its ability to promote phagocytic cell effector functions. A comprehensive understanding of the discrete T cell subsets critical for site-specific IL-17-mediated bacterial clearance will therefore be necessary to inform the development of vaccines that efficiently target cellular immunity. In this study, we have identified a population of CD44+CD27- memory γδ T cells, expanded upon infection of C57BL/6 mice with S. aureus, which produce high levels of IL-17 and mediate enhanced bacterial clearance upon reinfection with the bacterium. These cells are comprised largely of the Vγ4+ subset and accumulate at the site of infection subsequent to an initial Vγ1.1+ and Vγ2+ T cell response. Moreover, these Vγ4+ T cells are retained in the peritoneum and draining mediastinal lymph nodes for a prolonged period following bacterial clearance. In contrast to its critical requirement for γδ T cell activation during the primary infection, IL-1 signaling was dispensable for activation and expansion of memory γδ T cells upon re-exposure to S. aureus. Our findings demonstrate that a γδ T cell memory response can be induced upon exposure to S. aureus, in a fashion analogous to that associated with classical αβ T cells, and suggest that induction of IL-17-expressing γδ T cells may be an important property of a protective vaccine against S. aureus. [ABSTRACT FROM AUTHOR]

This Note explores the effect of the United States' ratification of the Hague Convention on the Protection of Children and Cooperation in Respect of Intercountry Adoption (Hague Convention) via passage of the Intercountry Adoption Act of 2000 (IAA). Through intercountry adoption, countless children have been given homes and opportunities in the U.S. that would not have been available to them in their countries of origin. With the increased popularity of intercountry adoption, however, have come tragic consequences for many children in foreign countries, who are exploited by those involved in the adoption process. This Note contends that the IAA, as currently written, does not sufficiently address these problems. After examining the history of intercountry adoption, the Hague Convention, and the IAA, the Note proposes certain changes in the IAA that would help combat the problems posed by intercountry adoption and allow its beneficial aspects to continue. [ABSTRACT FROM AUTHOR]

Background: Bovine Viral Diarrhoea Virus (BVDV) infection remains endemic in many countries worldwide. Ireland, in common with several other European counties, commenced an BVDV eradication programme in the last decade, Managing eradication programmes requires careful monitoring of diseases prevalence and understanding factors associated with disease exposure to ensure eradication programmes remain evidence based and tailored to the evolving epidemiological situation. Methods: In this study, we explore the seroprevalence of BVDV exposure over a four-year period (2017 to 2020) in Ireland from a cohort of animals (n = 6,449) under 30 months of age sampled at slaughter, who were born subsequent to the commencement of a compulsory national eradication programme. Temporal trends and risk factor analysis were undertaken using multilevel logit regression models. Results: There was a declining temporal trend in seroprevalence over the sample years of the study, and risk varied at both county- and herd-levels. The unadjusted marginal animal-level seroprevalence reduced from 9.1% in 2017 (95%; CI: 7.2—10.9) to 3.9% in 2020 (95%; CI: 3.2—4.6). The final model suggested that seropositivity in study cattle was strongly related with the presence of a PI animal in the herd during the year of the animal's birth, and to a lesser extent the status of the herd from which the animal was slaughtered. The risk of seroconversion increased significantly with increasing size of the herd of slaughter, in females relative to males, and in dairy relative to suckler herds. Conclusions: This study has shown that the BVDV serostatus of cattle at slaughter is correlated to the BVD infection history of the herd into which the animal was born and the herd from which it was slaughtered. Herd location, increased herd size and dairy production were associated with increased probability of serconversion. These findings will be used to inform the targeting of surveillance strategies once BVDV freedom has been achieved. [ABSTRACT FROM AUTHOR]